Insulin Delivery Pens Market
Insulin Delivery Pens Market by Product, Technology, Distribution Channel, & Region | Forecast 2022 to 2032
Can Signing of New Contracts and Launch of Novel Products Generate Revenue for Insulin Delivery Pens Manufacturers? Get Exclusive Details in FMI's Study!
Insulin Delivery Pens Market Outlook (2022 to 2032)
The global insulin delivery pens market is expected to reach a valuation of US$ 22.4 Billion by the end of 2022, and further expand at a CAGR of 8.0% to reach a valuation of US$ 48.6 Billion by the end of 2032. According to a recent study by Future Market Insights, smart insulin pens by-products are leading the market and held a share of about 34.6% in the year 2021.
Diabetes management frequently necessitates taking insulin shots throughout the day. Insulin delivery technologies such as insulin pens can make it considerably easier to administer insulin shots. The usage of a vial and syringe to give insulin can be replaced with an insulin pen, making diabetes management easier for patients. Insulin pens do not eliminate the necessity for needle pricks. They simply make measuring and administering insulin easier.
Insulin pens can give between 0.5 and 80 units of insulin at a time. They can deliver insulin in half-unit, one-unit, or two-unit intervals. The maximum dose and incremental amount differ between pens. The overall number of insulin units in the cartridges varies as well. Insulin pens are a practical way to control one’s levels of blood sugar. Insulin pens are compact and portable, containing medicine and a syringe packed within one device, making them a perfect solution for individuals on the go.
In addition, diabetes is a leading cause of kidney failure, blindness, heart attacks, amputation of lower limbs, and stroke. Diabetes-related premature mortality increased by 5% between 2000 and 2016. Regular physical activity, a nutritious diet, maintaining a normal body weight, and moving away from tobacco use are all approaches to avoiding or postponing the onset of type 2 diabetes. Thus, owing to the aforementioned factors, the global insulin delivery pens market is expected to grow at a CAGR of 8.0% during the forecast period from 2022 to 2032.
However, individual insulin pens stored or distributed outside of their box pose an increased risk of dispensing errors and patients using the wrong substance. Individually delivered insulin pens outside of their boxes may have contributed to medication errors such as wrong-dose and wrong-drug errors, thereby resulting in hyperglycaemia or hypoglycaemia, missing doses, allegations of potential tampering, and delivery without directions for the usage which may lead to hindrance for the market to grow. These factors are anticipated to negatively impact the insulin delivery pens market.
Apart from that, several companies are nowadays participating in mergers & acquisitions and collaborations & partnerships with local players to compete with their rivals. In October 2022, BIOCORP, a leading manufacturer of unique medical devices based in France, joined hands with Merck KGaA, a Germany-based technology company, to create and supply a specific version of Mallya device as an important accessory for one of Merck KGaA’s drug delivery devices.
Moreover, in March 2022, Novo Nordisk introduced its latest smart insulin pens in the United Kingdom to provide National Health Service (NHS) diabetes patients with the ability to monitor and note dosing information. The company is aiming to compete with its rivals, namely, Sanofi and Eli Lilly in the highly competitive insulin sector.
Attributes |
Key Insights |
Global Insulin Delivery Pens Market Estimated Size (2022E) |
US$ 22.4 Billion |
Projected Market Valuation (2032F) |
US$ 48.6 Billion |
Value-based CAGR (2022 to 2032) |
8.0% |
Collective Value Share: Top 5 Countries |
57.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2014 to 2021 Global Insulin Delivery Pens Market Outlook Compared to 2022 to 2032 Demand Forecast
The global insulin delivery pens market held approximately 3.3% of the global injectable drug delivery market, which was worth US$ 624.5 Billion in 2021. Sales of insulin delivery pens expanded at a CAGR of 6.5% from 2014 to 2021.
Insulin pens are becoming increasingly popular, and many diabetics nowadays use a pen to inject insulin. These pens make insulin delivery easier, more accurate, and more convenient than a vial or syringe. Not everyone with diabetes will require insulin, especially those who do discover that adhering to an insulin schedule can be hard, disruptive, and depleting. Some patients prefer insulin pens to make insulin administration less obtrusive and cumbersome. Demand in the insulin pen market will be boosted in the next decade as the prevalence of diabetes is on the rise.
The World Health Organization (WHO) in November 2021, stated that diabetes is a long-term condition that develops when the pancreas is unable to produce sufficient insulin or when the body fails to adequately utilize the insulin that is produced. Hyperglycaemia or high blood sugar is a typical side effect of untreated diabetes, and it can cause some serious harm to many of the body functions, particularly the neurons and blood vessels, over time. Hyperglycaemia impacted 8.5% of individuals aged 18 and up in 2014. Diabetes was the primary consequence of 1.5 million fatalities in 2019, with 48% of all diabetes-related mortalities before the age of 70. are frequently more expensive than a vial of insulin. If the gadget must be primed before injection, some insulin is squandered. Access to life-saving medication is a luxury that many people in the USA cannot afford.
Soaring drug prices and insufficient health insurance coverage can result in unpayable out-of-pocket expenses, undermining the right to health, driving people into financial distress & debt, and disproportionately affecting people who are socially and economically marginalized, reinforcing existing forms of structural discrimination.
For instance, a box of five Humalog KwikPens can cost more than $600 depending on a person’s insurance and the drugstore one visits, while the recently available authorized generic can cost more than $300. Each pen is filled with 3 mL of insulin. Admelog prices vary by the drug store, but a box of five 3-mL insulin-prefilled pens costs around $150.
Top Trends Fostering Sales in the Insulin Delivery Pens Market
- Development of Smart Insulin Caps to Bode Well for Insulin Delivery Pens Manufacturers
The market is likely to provide an opportunistic perspective owing to initiatives by governments in emerging countries that are engaging significantly in healthcare infrastructure development, which is expected to broaden access to healthcare services. It is further expected to boost demand for better technologies, creating an appealing opportunity in the global insulin delivery pens market.
Technological developments and the use of innovative designs that are chosen over traditional insulin administration techniques such as syringes and needles would push the market. Insulin pens are supporting smartphone and internet technologies, which would speed up and improve the accuracy of the administration process.
Emerging market participants are working on developing enhanced gadgets such as smart pens and smart insulin caps that can be connected via mobile technologies. Because of the internet's significance, e-commerce has grown in terms of popularity in recent years.
Furthermore, due to social distancing regulations, the COVID-19 pandemic has produced a scenario in which e-commerce is mainly preferred. As a result, the online availability of diabetes management solutions would provide significant market growth prospects.
What are the Factors Restraining the Demand for Insulin Delivery Pens?
The rising cost and how technology advances in the healthcare field can hamper growth in the insulin delivery pens market during the forecast period. Insulin pens are frequently more expensive than a vial of insulin. If the gadget must be primed before injection, some insulin is squandered. Access to life-saving medication is a luxury that many people in the USA cannot afford.
Soaring drug prices and insufficient health insurance coverage can result in unpayable out-of-pocket expenses, undermining the right to health, driving people into financial distress & debt, and disproportionately affecting people who are socially and economically marginalized, reinforcing existing forms of structural discrimination.
For instance, a box of five Humalog KwikPens can cost more than $600 depending on a person’s insurance and the drugstore one visits, while the recently available authorized generic can cost more than $300. Each pen is filled with 3 mL of insulin. Admelog prices vary by the drug store, but a box of five 3-mL insulin-prefilled pens costs around $150.
Country-wise Insights
Why is the USA Set to Remain at the Forefront in the Field of Insulin Delivery Pens?
High Prevalence of Hyperglycaemia in the U.S. to Fuel Sales of Insulin Syringes
The USA dominated the North American region with a total market share of over 80% in 2021 and is expected to continue to experience promising growth throughout the forecast period. According to Human Rights Watch 2018, about 27 million adults in the United States were diagnosed with diabetes, and roughly 8.2 million adults used one or more insulin formulations to control their blood sugar. People who require insulin may have hyperglycaemia or high blood sugar, which can lead to significant and even life-threatening consequences. It is anticipated to push growth in the insulin pen market in the USA in the coming decade.
Why Are Insulin Delivery Pens Manufacturers Exhibiting Lucrative Growth in China?
Patients with Inadequate Glycaemic Control in China to Use Reusable Insulin Pen Devices
China held approximately 54% of the share in the East Asia insulin delivery pens market in 2021 and is likely to witness growth at a lucrative CAGR of 10.1% during the forecast period. According to the International Diabetes Federation’s (IDF) Diabetes Atlas 2018, China has the world's highest diabetes population of 109.6 million, which is imposing a significant healthcare burden on society.
Diabetes is inadequately managed in China, with less than half of individuals diagnosed achieving the HbA1c goal threshold of 7.0% (53 mmol/mol). Insulin is indicated in both national and international diabetes care guidelines for patients with inadequate glycaemic control who are receiving oral antihyperglycemic medications.
What is the Outlook of Germany in the Insulin Delivery Pens Industry?
Availability of Bluetooth-enabled Insulin Injection Pens to Drive Growth in Germany
Germany is set to exhibit a CAGR of nearly 9.3% in the Europe insulin delivery pens market during the forecast period. Emperra GmbH, which is based in Germany, launched its first Bluetooth insulin pen in August 2016. Emperra is thus the only firm that can reach individuals with diabetes of all ages through a holistic creative strategy of digital solutions with smart insulin pens. As a result, the greatest community of older type 2 diabetics on insulin is being digitally accessed for the first time in Germany.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Category-wise Insights
Which is the Highly Preferred Insulin Delivery Pen across the Globe?
Smart Ultra Fine Pen Needles to Gain Impetus with Their Ability to Prevent Skipped Doses
Smart insulin pens are expected to showcase high growth at a CAGR of 6.3% by the end of the forecast period. The segment had captured nearly one-third of the share in the global market in 2021 owing to various beneficial factors like the provision of precise half-unit doses, assisting in preventing missing or skipped doses, and notifications on how to treat a high blood sugar readings, keeping track of the duration & dosage of each administration, and set a reminder for the next one.
Which Technology is Trending in the Space of Insulin Delivery Pens?
Diabetic Pen Needles with Non-smart Injectors to Witness Immense Popularity by 2032
Non-smart injectors held a revenue share of nearly 84.6% in 2021 and are expected to witness steady growth in the insulin delivery pens market over the forecast period. Non-smart insulin injectors can provide several shots as they are pre-filled and allow for accurate dosing. This factor is expected to fuel the revenue growth of the segment over the forecast period.
Which Distribution Channel are Consumers Choosing to Purchase Insulin Delivery Pens?
Demand for Insulin Needles For Pens to Surge among Hospital Pharmacies Worldwide
Hospital pharmacies held the highest insulin delivery pens market share of over 35% in 2021. Increasing inpatient admissions and easy prescription-based medicines provided at hospital pharmacies are propelling sales of the overall insulin delivery pens market.
Competitive Landscape
There are several competitors in the global insulin delivery pens market. To meet the rising consumer demand and expand their customer base, these companies are implementing various strategies such as mergers & acquisitions, partnerships & collaborations, and new product launches.
Some of the recent developments by key players in the insulin delivery pens market are given below:
- In August 2019, Enable Injections, Inc. (Enable), a business developing and producing investigational wearable infusion devices for combination products, announced that it has entered into a development agreement with Genentech, a Roche Group subsidiary. Enable's enFuse will enable patient-administered subcutaneous delivery of high-volume medicines.
- In October 2019, West Pharmaceutical Services, Inc. launched ovaPure 3mL Cartridge components and SmartDose Gen. II 10mL injector at the 2019 PDA Universe of Pre-Filled Syringes and Injection Devices (PDA PFS).
Scope of the Insulin Delivery Pens Market Report
Attribute |
Details |
Estimated Market Size (2022) |
US$ 22424.7 Million |
Projected Market Valuation (2032) |
US$ 48626.3 Million |
Value-based CAGR (2022 to 2032) |
8.0% |
Forecast Period |
2014 to 2021 |
Historical Data Available for |
2022 to 2032 |
Market Analysis |
Value (US$ Million) |
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered |
USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa |
Key Market Segments Covered |
Product, Technology, Distribution Channel, and Region |
Key Companies Profiled |
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Key Segments Covered in Insulin Delivery Pens Market Report
By Product:
- Reusable Insulin Pens
- Disposable Insulin Pens
- Smart Insulin Pens
By Technology:
- Non-Smart Injectors
- Smart Injectors
- Artificial Intelligence (AI) & Machine Learning Integrated
- Near Field Communication(NFR)
- Cloud Computing
- Bluetooth
By Distribution Channel:
- Hospital Pharmacies
- Drug Stores
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
How much is the insulin delivery pens market estimated to be worth in 2022?
The global insulin delivery pens market is estimated to be worth US$ 22.4 Billion in 2021 and is set to expand 2.2x over the next ten years.
What is the sales forecast for the insulin delivery pens market through 2032?
The insulin delivery pens market is expected to reach US$ 48.6 Billion by the end of 2032, with sales revenue anticipated to register an 8.0% CAGR.
What are the key trends shaping the insulin delivery pens industry?
The growing prevalence of diabetes, innovative product development, and increasing adoption of insulin pens are some of the key trends in the insulin delivery pens market.
Which are the top five countries driving demand for insulin delivery pens?
The USA, India, China, Germany, and Japan are expected to drive demand in the insulin delivery pens market.
What is the North America insulin delivery pens market outlook?
North America is one of the key markets for insulin delivery pens, with the USA accounting for about 84.8% of the North America insulin delivery pens market in 2021
At what percentage is the demand for insulin delivery pens expected to register growth in Europe?
Demand for insulin delivery pens in Europe is expected to register growth at a CAGR of 7.8% over the next ten years.
At what CAGR is the insulin delivery pens market expected to register growth in Latin America?
Demand for insulin delivery pens in Latin America is expected to register a CAGR of 7.6% over the next ten years
Which countries are the key producers of insulin delivery pens?
China, the USA, and Germany are the key producers of insulin delivery pens.
Who are the key players in the insulin delivery pens market?
Eli Lilly and Company, Becton, Dickinson & Company, West Pharmaceutical Services, Inc, Johnson & Johnson, Antares Pharma, AbbVie Inc., Pfizer Inc, Mylan N.V, Vetter Pharma-Fertigung GmbH & Co.KG, Emperra GmbH, Digital Medics Pty Ltd, Enable Injections LLC, Insulet corporation, Consort Medical Plc, Diabnext, and Medtronic Plc are some of the key players in the insulin delivery pens market.
Table of Content
1. Executive Summary | Insulin Delivery Pens Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Disease Epidemiology 4.2. Patient Journey 4.3. Regulatory Scenario 4.4. Reimbursement Landscape 4.5. PESTEL analysis 4.6. Porter’s analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare GDP Growth Overview 5.1.3. Global Drug Delivery Market Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising prevalence of Diabetic cases. 5.2.2. Increasing awareness and adoption of Insulin Delivery Pen. 5.2.3. New Product Launches 5.2.4. Advancing medical technology and developments of Insulin Delivery Pen. 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis - Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Technology 6.1.3. By Distribution Channel 6.1.4. By Region 6.2. 2021 Market Scenario 7. Global Market Volume (Units) Analysis 2014 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Volume (Units) Analysis, 2014 to 2021 7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer-Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2032 9.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021 9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2032, by Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2014 to 2021 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032 10.3.1. Reusable Insulin Pens 10.3.2. Disposable Insulin Pens 10.3.3. Smart Insulin Pens 10.4. Market Attractiveness Analysis By Product 11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2032, by Technology 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Technology, 2014 to 2021 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technology, 2022 to 2032 11.3.1. Non-Smart Injectors 11.3.2. Smart Injectors 11.3.2.1. Artificial Intelligence (AI) & Machine Learning Integrated 11.3.2.2. Near Field Communication(NFR) 11.3.2.3. Cloud Computing 11.3.2.4. Bluetooth 11.4. Market Attractiveness Analysis By Technology 12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2032, by Distribution Channel 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis, By Distribution Channel, 2014 to 2021 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2022 to 2032 12.3.1. Hospital Pharmacies 12.3.2. Drug Stores 12.3.3. Retail Pharmacies 12.3.4. Online Pharmacies 12.4. Market Attractiveness Analysis By Distribution Channel 13. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2032, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2014 to 2021 13.3. Current Market and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2022 to 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021 14.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. USA 14.4.1.2. Canada 14.4.2. By Product 14.4.3. By Technology 14.4.4. By Distribution Channel 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product 14.5.3. By Technology 14.5.4. By Distribution Channel 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 14.9. Country-Level Analysis & Forecast 14.9.1. USA Market Analysis 14.9.1.1. .Introduction 14.9.1.2. Market Analysis and Forecast by Market Taxonomy 14.9.1.2.1. By Product 14.9.1.2.2. By Technology 14.9.1.2.3. By Distribution Channel 14.9.2. Canada Market Analysis 14.9.2.1. Introduction 14.9.2.2. Market Analysis and Forecast by Market Taxonomy 14.9.2.2.1. By Product 14.9.2.2.2. By Technology 14.9.2.2.3. By Distribution Channel 15. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021 15.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. Mexico 15.4.1.2. Brazil 15.4.1.3. Argentina 15.4.1.4. Rest of Latin America 15.4.2. By Product 15.4.3. By Technology 15.4.4. By Distribution Channel 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product 15.5.3. By Technology 15.5.4. By Distribution Channel 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 15.9. Country-Level Analysis & Forecast 15.9.1. Mexico Market Analysis 15.9.1.1. Introduction 15.9.1.2. Market Analysis and Forecast by Market Taxonomy 15.9.1.2.1. By Product 15.9.1.2.2. By Technology 15.9.1.2.3. By Distribution Channel 15.9.2. Brazil Market Analysis 15.9.2.1. Introduction 15.9.2.2. Market Analysis and Forecast by Market Taxonomy 15.9.2.2.1. By Product 15.9.2.2.2. By Technology 15.9.2.2.3. By Distribution Channel 15.9.3. Argentina Market Analysis 15.9.3.1. Introduction 15.9.3.2. Market Analysis and Forecast by Market Taxonomy 15.9.3.2.1. By Product 15.9.3.2.2. By Technology 15.9.3.2.3. By Distribution Channel 16. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021 16.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. Germany 16.4.1.2. Italy 16.4.1.3. France 16.4.1.4. United Kingdom 16.4.1.5. Spain 16.4.1.6. BENELUX 16.4.1.7. Russia 16.4.1.8. Rest of Europe 16.4.2. By Product 16.4.3. By Technology 16.4.4. By Distribution Channel 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product 16.5.3. By Technology 16.5.4. By Distribution Channel 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 16.9. Country-Level Analysis & Forecast 16.9.1. Germany Market Analysis 16.9.1.1. Introduction 16.9.1.2. Market Analysis and Forecast by Market Taxonomy 16.9.1.2.1. By Product 16.9.1.2.2. By Technology 16.9.1.2.3. By Distribution Channel 16.9.2. Italy Market Analysis 16.9.2.1. Introduction 16.9.2.2. Market Analysis and Forecast by Market Taxonomy 16.9.2.2.1. By Product 16.9.2.2.2. By Technology 16.9.2.2.3. By Distribution Channel 16.9.3. France Market Analysis 16.9.3.1. Introduction 16.9.3.2. Market Analysis and Forecast by Market Taxonomy 16.9.3.2.1. By Product 16.9.3.2.2. By Technology 16.9.3.2.3. By Distribution Channel 16.9.4. United Kingdom Market Analysis 16.9.4.1. Introduction 16.9.4.2. Market Analysis and Forecast by Market Taxonomy 16.9.4.2.1. By Product 16.9.4.2.2. By Technology 16.9.4.2.3. By Distribution Channel 16.9.5. Spain Market Analysis 16.9.5.1. Introduction 16.9.5.2. Market Analysis and Forecast by Market Taxonomy 16.9.5.2.1. By Product 16.9.5.2.2. By Technology 16.9.5.2.3. By Distribution Channel 16.9.6. BENELUX Market Analysis 16.9.6.1. Introduction 16.9.6.2. Market Analysis and Forecast by Market Taxonomy 16.9.6.2.1. By Product 16.9.6.2.2. By Technology 16.9.6.2.3. By Distribution Channel 16.9.7. Russia Market Analysis 16.9.7.1. Introduction 16.9.7.2. Market Analysis and Forecast by Market Taxonomy 16.9.7.2.1. By Product 16.9.7.2.2. By Technology 16.9.7.2.3. By Distribution Channel 17. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021 17.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 17.4.1. By Country 17.4.1.1. India 17.4.1.2. Indonesia 17.4.1.3. Malaysia 17.4.1.4. Thailand 17.4.1.5. Rest of South Asia 17.4.2. By Product 17.4.3. By Technology 17.4.4. By Distribution Channel 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Product 17.5.3. By Technology 17.5.4. By Distribution Channel 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 17.9. Country-Level Analysis & Forecast 17.9.1. India Market Analysis 17.9.1.1. Introduction 17.9.1.2. Market Analysis and Forecast by Market Taxonomy 17.9.1.2.1. By Product 17.9.1.2.2. By Technology 17.9.1.2.3. By Distribution Channel 17.9.2. Indonesia Market Analysis 17.9.2.1. Introduction 17.9.2.2. Market Analysis and Forecast by Market Taxonomy 17.9.2.2.1. By Product 17.9.2.2.2. By Technology 17.9.2.2.3. By Distribution Channel 17.9.3. Malaysia Market Analysis 17.9.3.1. Introduction 17.9.3.2. Market Analysis and Forecast by Market Taxonomy 17.9.3.2.1. By Product 17.9.3.2.2. By Technology 17.9.3.2.3. By Distribution Channel 17.9.4. Thailand Market Analysis 17.9.4.1. Introduction 17.9.4.2. Market Analysis and Forecast by Market Taxonomy 17.9.4.2.1. By Product 17.9.4.2.2. By Technology 17.9.4.2.3. By Distribution Channel 18. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021 18.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 18.4.1. By Country 18.4.1.1. China 18.4.1.2. Japan 18.4.1.3. South Korea 18.4.2. By Product 18.4.3. By Technology 18.4.4. By Distribution Channel 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Product 18.5.3. By Technology 18.5.4. By Distribution Channel 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 18.9. Country-Level Analysis & Forecast 18.9.1. China Market Analysis 18.9.1.1. Introduction 18.9.1.2. Market Analysis and Forecast by Market Taxonomy 18.9.1.2.1. By Product 18.9.1.2.2. By Technology 18.9.1.2.3. By Distribution Channel 18.9.2. Japan Market Analysis 18.9.2.1. Introduction 18.9.2.2. Market Analysis and Forecast by Market Taxonomy 18.9.2.2.1. By Product 18.9.2.2.2. By Technology 18.9.2.2.3. By Distribution Channel 18.9.3. South Korea Market Analysis 18.9.3.1. Introduction 18.9.3.2. Market Analysis and Forecast by Market Taxonomy 18.9.3.2.1. By Product 18.9.3.2.2. By Technology 18.9.3.2.3. By Distribution Channel 19. Oceania Market 2017 to 2021 and Forecast 2022 to 2032 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021 19.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 19.4.1. By Country 19.4.1.1. Australia 19.4.1.2. New Zealand 19.4.2. By Product 19.4.3. By Technology 19.4.4. By Distribution Channel 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Product 19.5.3. By Technology 19.5.4. By Distribution Channel 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country-Level Analysis & Forecast 19.8.1. Australia Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Technology 19.8.1.2.3. By Distribution Channel 19.8.2. New Zealand Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Technology 19.8.2.2.3. By Distribution Channel 20. Middle East and Africa (MEA) Market Analysis 2014 to 2021 and Forecast 2022 to 2032 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2014 to 2021 20.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2022 to 2032 20.4.1. By Country 20.4.1.1. GCC Countries 20.4.1.2. Turkey 20.4.1.3. South Africa 20.4.1.4. North Africa 20.4.1.5. Rest of Middle East and Africa 20.4.2. By Product 20.4.3. By Technology 20.4.4. By Distribution Channel 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Product 20.5.3. By Technology 20.5.4. By Distribution Channel 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 20.9. Country-Level Analysis & Forecast 20.9.1. GCC Countries Market Analysis 20.9.1.1. Introduction 20.9.1.2. Market Analysis and Forecast by Market Taxonomy 20.9.1.2.1. By Product 20.9.1.2.2. By Technology 20.9.1.2.3. By Distribution Channel 20.9.2. Turkey Market Analysis 20.9.2.1. Introduction 20.9.2.2. Market Analysis and Forecast by Market Taxonomy 20.9.2.2.1. By Product 20.9.2.2.2. By Technology 20.9.2.2.3. By Distribution Channel 20.9.3. South Africa Market Analysis 20.9.3.1. Introduction 20.9.3.2. Market Analysis and Forecast by Market Taxonomy 20.9.3.2.1. By Product 20.9.3.2.2. By Technology 20.9.3.2.3. By Distribution Channel 20.9.4. North Africa Market Analysis 20.9.4.1. Introduction 20.9.4.2. Market Analysis and Forecast by Market Taxonomy 20.9.4.2.1. By Product 20.9.4.2.2. By Technology 20.9.4.2.3. By Distribution Channel 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Becton, Dickinson, and Company 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Sales Footprint 22.3.1.4. SWOT Analysis 22.3.1.5. Key Financials 22.3.1.6. Strategy Overview 22.3.1.7. Eli Lilly and Company Overview 22.3.1.8. Product Portfolio 22.3.1.9. Sales Footprint 22.3.1.10. SWOT Analysis 22.3.1.11. Key Financials 22.3.1.12. Strategy Overview 22.3.2. West Pharmaceutical Services, Inc 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Sales Footprint 22.3.2.4. SWOT Analysis 22.3.2.5. Key Financials 22.3.2.6. Strategy Overview 22.3.3. Johnson & Johnson 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Sales Footprint 22.3.3.4. SWOT Analysis 22.3.3.5. Key Financials 22.3.3.6. Strategy Overview 22.3.4. Antares Pharma 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Sales Footprint 22.3.4.4. SWOT Analysis 22.3.4.5. Key Financials 22.3.4.6. Strategy Overview 22.3.5. AbbVie Inc. 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Sales Footprint 22.3.5.4. SWOT Analysis 22.3.5.5. Key Financials 22.3.5.6. Strategy Overview 22.3.6. Pfizer Inc 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Sales Footprint 22.3.6.4. SWOT Analysis 22.3.6.5. Key Financials 22.3.6.6. Strategy Overview 22.3.7. Mylan N.V 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Sales Footprint 22.3.7.4. SWOT Analysis 22.3.7.5. Key Financials 22.3.7.6. Strategy Overview 22.3.8. Vetter Pharma-Fertigung GmbH & Co.KG 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Sales Footprint 22.3.8.4. SWOT Analysis 22.3.8.5. Key Financials 22.3.8.6. Strategy Overview 22.3.9. Emperra GmbH 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Sales Footprint 22.3.9.4. SWOT Analysis 22.3.9.5. Key Financials 22.3.9.6. Strategy Overview 22.3.10. Digital Medics Pty Ltd 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Sales Footprint 22.3.10.4. SWOT Analysis 22.3.10.5. Key Financials 22.3.10.6. Strategy Overview 22.3.11. Enable Injections LLC 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Sales Footprint 22.3.11.4. SWOT Analysis 22.3.11.5. Key Financials 22.3.11.6. Strategy Overview 22.3.12. Insulet corporation 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Sales Footprint 22.3.12.4. SWOT Analysis 22.3.12.5. Key Financials 22.3.12.6. Strategy Overview 22.3.13. Consort Medical Plc 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Sales Footprint 22.3.13.4. SWOT Analysis 22.3.13.5. Key Financials 22.3.13.6. Strategy Overview 22.3.14. Diabnext 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Sales Footprint 22.3.14.4. SWOT Analysis 22.3.14.5. Key Financials 22.3.14.6. Strategy Overview 22.3.15. Diamesco Co., Ltd 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Sales Footprint 22.3.15.4. SWOT Analysis 22.3.15.5. Key Financials 22.3.15.6. Strategy Overview 22.3.16. SCHOTT AG 22.3.16.1. Overview 22.3.16.2. Product Portfolio 22.3.16.3. Sales Footprint 22.3.16.4. SWOT Analysis 22.3.16.5. Key Financials 22.3.16.6. Strategy Overview 22.3.17. SiO2 Medical Products 22.3.17.1. Overview 22.3.17.2. Product Portfolio 22.3.17.3. Sales Footprint 22.3.17.4. SWOT Analysis 22.3.17.5. Key Financials 22.3.17.6. Strategy Overview 22.3.18. Integrity Bio, Inc. 22.3.18.1. Overview 22.3.18.2. Product Portfolio 22.3.18.3. Sales Footprint 22.3.18.4. SWOT Analysis 22.3.18.5. Key Financials 22.3.18.6. Strategy Overview 22.3.19. Wilhelm Haselmeier GmbH & Co. KG 22.3.19.1. Overview 22.3.19.2. Product Portfolio 22.3.19.3. Sales Footprint 22.3.19.4. SWOT Analysis 22.3.19.5. Key Financials 22.3.19.6. Strategy Overview 22.3.20. Tandem Diabetes Care 22.3.20.1. Overview 22.3.20.2. Product Portfolio 22.3.20.3. Sales Footprint 22.3.20.4. SWOT Analysis 22.3.20.5. Key Financials 22.3.20.6. Strategy Overview 22.3.21. Sanofi S.A. 22.3.21.1. Overview 22.3.21.2. Product Portfolio 22.3.21.3. Sales Footprint 22.3.21.4. SWOT Analysis 22.3.21.5. Key Financials 22.3.21.6. Strategy Overview 22.3.22. Companion Medical Inc. 22.3.22.1. Overview 22.3.22.2. Product Portfolio 22.3.22.3. Sales Footprint 22.3.22.4. SWOT Analysis 22.3.22.5. Key Financials 22.3.22.6. Strategy Overview 22.3.23. Ypsomed 22.3.23.1. Overview 22.3.23.2. Product Portfolio 22.3.23.3. Sales Footprint 22.3.23.4. SWOT Analysis 22.3.23.5. Key Financials 22.3.23.6. Strategy Overview 22.3.24. Hoffman - La Roche Ltd 22.3.24.1. Overview 22.3.24.2. Product Portfolio 22.3.24.3. Sales Footprint 22.3.24.4. SWOT Analysis 22.3.24.5. Key Financials 22.3.24.6. Strategy Overview 22.3.25. Novo Nordisk A/S 22.3.25.1. Overview 22.3.25.2. Product Portfolio 22.3.25.3. Sales Footprint 22.3.25.4. SWOT Analysis 22.3.25.5. Key Financials 22.3.25.6. Strategy Overview 22.3.26. Medtronic Plc. 22.3.26.1. Overview 22.3.26.2. Product Portfolio 22.3.26.3. Sales Footprint 22.3.26.4. SWOT Analysis 22.3.26.5. Key Financials 22.3.26.6. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product Table 02: Global Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product Table 03: Global Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology Table 04: Global Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel Table 05: Global Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Region Table 06: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country Table 07: North America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product Table 08: North America Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product Table 09: North America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology Table 10: North America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel Table 11: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country Table 12: Latin America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product Table 13: Latin America Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product Table 14: Latin America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology Table 15: Latin America Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel Table 16: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country Table 17: Europe Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product Table 18: Europe Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product Table 19: Europe Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology Table 20: Europe Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel Table 21: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country Table 22: South Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product Table 23: South Asia Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product Table 24: South Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology Table 25: South Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel Table 26: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country Table 27: East Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product Table 28: East Asia Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product Table 29: East Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology Table 30: East Asia Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel Table 31: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country Table 32: Oceania Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product Table 33: Oceania Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product Table 34: Oceania Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology Table 35: Oceania Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel Table 36: MEA Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country Table 37: MEA Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Product Table 38: MEA Market Volume (Units) Analysis and Forecast 2014 to 2032, by Product Table 39: MEA Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Technology Table 40: MEA Market Value (US$ Million) Analysis and Forecast 2014 to 2032, by Distribution Channel
List of Charts
Figure 01: Global Market Volume (Units), 2014 to 2021 Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 03: XYZ, Pricing Analysis per unit (US$), in 2022 Figure 04: XYZ, Pricing Forecast per unit (US$), in 2032 Figure 05: Global Market Value (US$ Million) Analysis, 2014 to 2021 Figure 06: Global Market Forecast & Y-o-Y Growth, 2022 to 2032 Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2021–2032 Figure 08: Global Market Value Share (%) Analysis 2022 and 2032, by Product Figure 09: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Product Figure 10: Global Market Attractiveness Analysis 2022 to 2032, by Product Figure 11: Global Market Value Share (%) Analysis 2022 and 2032, by Technology Figure 12: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Technology Figure 13: Global Market Attractiveness Analysis 2022 to 2032, by Technology Figure 14: Global Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel Figure 15: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Distribution Channel Figure 16: Global Market Attractiveness Analysis 2022 to 2032, by Distribution Channel Figure 17: Global Market Value Share (%) Analysis 2022 and 2032, by Region Figure 18: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Region Figure 19: Global Market Attractiveness Analysis 2022 to 2032, by Region Figure 20: North America Market Value (US$ Million) Analysis, 2014 to 2021 Figure 21: North America Market Value (US$ Million) Forecast, 2022 to 2032 Figure 22: North America Market Value Share, by Product (2022 E) Figure 23: North America Market Value Share, by Technology (2022 E) Figure 24: North America Market Value Share, by Distribution Channel (2022 E) Figure 25: North America Market Value Share, by Country (2022 E) Figure 26: North America Market Attractiveness Analysis by Product, 2022 to 2032 Figure 27: North America Market Attractiveness Analysis by Technology, 2022 to 2032 Figure 28: North America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032 Figure 29: North America Market Attractiveness Analysis by Country, 2022 to 2032 Figure 30: USA Market Value Proportion Analysis, 2021 Figure 31: Global Vs. USA Growth Comparison, 2021 to 2032 Figure 32: USA Market Share Analysis (%) by Product, 2021 & 2032 Figure 33: USA Market Share Analysis (%) by Technology, 2021 & 2032 Figure 34: USA Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 35: Canada Market Value Proportion Analysis, 2021 Figure 36: Global Vs. Canada. Growth Comparison, 2021 to 2032 Figure 37: Canada Market Share Analysis (%) by Product, 2021 & 2032 Figure 38: Canada Market Share Analysis (%) by Technology, 2021 & 2032 Figure 39: Canada Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 40: Latin America Market Value (US$ Million) Analysis, 2014 to 2021 Figure 41: Latin America Market Value (US$ Million) Forecast, 2022 to 2032 Figure 42: Latin America Market Value Share, by Product (2022 E) Figure 43: Latin America Market Value Share, by Technology (2022 E) Figure 44: Latin America Market Value Share, by Distribution Channel (2022 E) Figure 45: Latin America Market Value Share, by Country (2022 E) Figure 46: Latin America Market Attractiveness Analysis by Product, 2022 to 2032 Figure 47: Latin America Market Attractiveness Analysis by Technology, 2022 to 2032 Figure 48: Latin America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032 Figure 49: Latin America Market Attractiveness Analysis by Country, 2022 to 2032 Figure 50: Mexico Market Value Proportion Analysis, 2021 Figure 51: Global Vs Mexico Growth Comparison, 2021 to 2032 Figure 52: Mexico Market Share Analysis (%) by Product, 2021 & 2032 Figure 53: Mexico Market Share Analysis (%) by Technology, 2021 & 2032 Figure 54: Mexico Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 55: Brazil Market Value Proportion Analysis, 2021 Figure 56: Global Vs. Brazil. Growth Comparison, 2021 to 2032 Figure 57: Brazil Market Share Analysis (%) by Product, 2021 & 2032 Figure 58: Brazil Market Share Analysis (%) by Technology, 2021 & 2032 Figure 59: Brazil Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 60: Argentina Market Value Proportion Analysis, 2021 Figure 61: Global Vs Argentina Growth Comparison, 2021 to 2032 Figure 62: Argentina Market Share Analysis (%) by Product, 2021 & 2032 Figure 63: Argentina Market Share Analysis (%) by Technology, 2021 & 2032 Figure 64: Argentina Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 65: Europe Market Value (US$ Million) Analysis, 2014 to 2021 Figure 66: Europe Market Value (US$ Million) Forecast, 2022 to 2032 Figure 67: Europe Market Value Share, by Product (2022 E) Figure 68: Europe Market Value Share, by Technology (2022 E) Figure 69: Europe Market Value Share, by Distribution Channel (2022 E) Figure 70: Europe Market Value Share, by Country (2022 E) Figure 71: Europe Market Attractiveness Analysis by Product, 2022 to 2032 Figure 72: Europe Market Attractiveness Analysis by Technology, 2022 to 2032 Figure 73: Europe Market Attractiveness Analysis by Distribution Channel, 2022 to 2032 Figure 74: Europe Market Attractiveness Analysis by Country, 2022 to 2032 Figure 75: United Kingdom Market Value Proportion Analysis, 2021 Figure 76: Global Vs. United Kingdom Growth Comparison, 2021 to 2032 Figure 77: United Kingdom Market Share Analysis (%) by Product, 2021 & 2032 Figure 78: United Kingdom Market Share Analysis (%) by Technology, 2021 & 2032 Figure 79: United Kingdom Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 80: Germany Market Value Proportion Analysis, 2021 Figure 81: Global Vs. Germany Growth Comparison, 2021 to 2032 Figure 82: Germany Market Share Analysis (%) by Product, 2021 & 2032 Figure 83: Germany Market Share Analysis (%) by Technology, 2021 & 2032 Figure 84: Germany Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 85: Italy Market Value Proportion Analysis, 2021 Figure 86: Global Vs. Italy Growth Comparison, 2021 to 2032 Figure 87: Italy Market Share Analysis (%) by Product, 2021 & 2032 Figure 88: Italy Market Share Analysis (%) by Technology, 2021 & 2032 Figure 89: Italy Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 90: France Market Value Proportion Analysis, 2021 Figure 91: Global Vs France Growth Comparison, 2021 to 2032 Figure 92: France Market Share Analysis (%) by Product, 2021 & 2032 Figure 93: France Market Share Analysis (%) by Technology, 2021 & 2032 Figure 94: France Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 95: Spain Market Value Proportion Analysis, 2021 Figure 96: Global Vs Spain Growth Comparison, 2021 to 2032 Figure 97: Spain Market Share Analysis (%) by Product, 2021 & 2032 Figure 98: Spain Market Share Analysis (%) by Technology, 2021 & 2032 Figure 99: Spain Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 100: Russia Market Value Proportion Analysis, 2021 Figure 101: Global Vs Russia Growth Comparison, 2021 to 2032 Figure 102: Russia Market Share Analysis (%) by Product, 2021 & 2032 Figure 103: Russia Market Share Analysis (%) by Technology, 2021 & 2032 Figure 104: Russia Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 105: BENELUX Market Value Proportion Analysis, 2021 Figure 106: Global Vs BENELUX Growth Comparison, 2021 to 2032 Figure 107: BENELUX Market Share Analysis (%) by Product, 2021 & 2032 Figure 108: BENELUX Market Share Analysis (%) by Technology, 2021 & 2032 Figure 109: BENELUX Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 110: East Asia Market Value (US$ Million) Analysis, 2014 to 2021 Figure 111: East Asia Market Value (US$ Million) Forecast, 2022 to 2032 Figure 112: East Asia Market Value Share, by Product (2022 E) Figure 113: East Asia Market Value Share, by Technology (2022 E) Figure 114: East Asia Market Value Share, by Distribution Channel (2022 E) Figure 115: East Asia Market Value Share, by Country (2022 E) Figure 116: East Asia Market Attractiveness Analysis by Product, 2022 to 2032 Figure 117: East Asia Market Attractiveness Analysis by Technology, 2022 to 2032 Figure 118: East Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032 Figure 119: East Asia Market Attractiveness Analysis by Country, 2022 to 2032 Figure 120: China Market Value Proportion Analysis, 2021 Figure 121: Global Vs. China Growth Comparison, 2021 to 2032 Figure 122: China Market Share Analysis (%) by Product, 2021 & 2032 Figure 123: China Market Share Analysis (%) by Technology, 2021 & 2032 Figure 124: China Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 125: Japan Market Value Proportion Analysis, 2021 Figure 126: Global Vs. Japan Growth Comparison, 2021 to 2032 Figure 127: Japan Market Share Analysis (%) by Product, 2021 & 2032 Figure 128: Japan Market Share Analysis (%) by Technology, 2021 & 2032 Figure 129: Japan Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 130: South Korea Market Value Proportion Analysis, 2021 Figure 131: Global Vs South Korea Growth Comparison, 2021 to 2032 Figure 132: South Korea Market Share Analysis (%) by Product, 2021 & 2032 Figure 133: South Korea Market Share Analysis (%) by Technology, 2021 & 2032 Figure 134: South Korea Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 135: South Asia Market Value (US$ Million) Analysis, 2014 to 2021 Figure 136: South Asia Market Value (US$ Million) Forecast, 2022 to 2032 Figure 137: South Asia Market Value Share, by Product (2022 E) Figure 138: South Asia Market Value Share, by Technology (2022 E) Figure 139: South Asia Market Value Share, by Distribution Channel (2022 E) Figure 140: South Asia Market Value Share, by Country (2022 E) Figure 141: South Asia Market Attractiveness Analysis by Product, 2022 to 2032 Figure 142: South Asia Market Attractiveness Analysis by Technology, 2022 to 2032 Figure 143: South Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032 Figure 144: South Asia Market Attractiveness Analysis by Country, 2022 to 2032 Figure 145: India Market Value Proportion Analysis, 2021 Figure 146: Global Vs. India Growth Comparison, 2021 to 2032 Figure 147: India Market Share Analysis (%) by Product, 2021 & 2032 Figure 148: India Market Share Analysis (%) by Technology, 2021 & 2032 Figure 149: India Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 150: Indonesia Market Value Proportion Analysis, 2021 Figure 151: Global Vs. Indonesia Growth Comparison, 2021 to 2032 Figure 152: Indonesia Market Share Analysis (%) by Product, 2021 & 2032 Figure 153: Indonesia Market Share Analysis (%) by Technology, 2021 & 2032 Figure 154: Indonesia Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 155: Malaysia Market Value Proportion Analysis, 2021 Figure 156: Global Vs. Malaysia Growth Comparison, 2021 to 2032 Figure 157: Malaysia Market Share Analysis (%) by Product, 2021 & 2032 Figure 158: Malaysia Market Share Analysis (%) by Technology, 2021 & 2032 Figure 159: Malaysia Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 160: Thailand Market Value Proportion Analysis, 2021 Figure 161: Global Vs. Thailand Growth Comparison, 2021 to 2032 Figure 162: Thailand Market Share Analysis (%) by Product, 2021 & 2032 Figure 163: Thailand Market Share Analysis (%) by Technology, 2021 & 2032 Figure 164: Thailand Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 165: Oceania Market Value (US$ Million) Analysis, 2014 to 2021 Figure 166: Oceania Market Value (US$ Million) Forecast, 2022 to 2032 Figure 167: Oceania Market Value Share, by Product (2022 E) Figure 168: Oceania Market Value Share, by Technology (2022 E) Figure 169: Oceania Market Value Share, by Distribution Channel (2022 E) Figure 170: Oceania Market Value Share, by Country (2022 E) Figure 171: Oceania Market Attractiveness Analysis by Product, 2022 to 2032 Figure 172: Oceania Market Attractiveness Analysis by Technology, 2022 to 2032 Figure 173: Oceania Market Attractiveness Analysis by Distribution Channel, 2022 to 2032 Figure 174: Oceania Market Attractiveness Analysis by Country, 2022 to 2032 Figure 175: Australia Market Value Proportion Analysis, 2021 Figure 176: Global Vs. Australia Growth Comparison, 2021 to 2032 Figure 177: Australia Market Share Analysis (%) by Product, 2021 & 2032 Figure 178: Australia Market Share Analysis (%) by Technology, 2021 & 2032 Figure 179: Australia Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 180: New Zealand Market Value Proportion Analysis, 2021 Figure 181: Global Vs New Zealand Growth Comparison, 2021 to 2032 Figure 182: New Zealand Market Share Analysis (%) by Product, 2021 & 2032 Figure 183: New Zealand Market Share Analysis (%) by Technology, 2021 & 2032 Figure 184: New Zealand Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 185: Middle East & Africa Market Value (US$ Million) Analysis, 2014 to 2021 Figure 186: Middle East & Africa Market Value (US$ Million) Forecast, 2022 to 2032 Figure 187: Middle East & Africa Market Value Share, by Product (2022 E) Figure 188: Middle East & Africa Market Value Share, by Technology (2022 E) Figure 189: Middle East & Africa Market Value Share, by Distribution Channel (2022 E) Figure 190: Middle East & Africa Market Value Share, by Country (2022 E) Figure 191: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2032 Figure 192: Middle East & Africa Market Attractiveness Analysis by Technology, 2022 to 2032 Figure 193: Middle East & Africa Market Attractiveness Analysis by Distribution Channel, 2022 to 2032 Figure 194: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032 Figure 195: GCC Countries Market Value Proportion Analysis, 2021 Figure 196: Global Vs GCC Countries Growth Comparison, 2021 to 2032 Figure 197: GCC Countries Market Share Analysis (%) by Product, 2021 & 2032 Figure 198: GCC Countries Market Share Analysis (%) by Technology, 2021 & 2032 Figure 199: GCC Countries Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 200: Turkey Market Value Proportion Analysis, 2021 Figure 201: Global Vs. Turkey Growth Comparison, 2021 to 2032 Figure 202: Turkey Market Share Analysis (%) by Product, 2021 & 2032 Figure 203: Turkey Market Share Analysis (%) by Technology, 2021 & 2032 Figure 204: Turkey Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 205: South Africa Market Value Proportion Analysis, 2021 Figure 206: Global Vs. South Africa Growth Comparison, 2021 to 2032 Figure 207: South Africa Market Share Analysis (%) by Product, 2021 & 2032 Figure 208: South Africa Market Share Analysis (%) by Technology, 2021 & 2032 Figure 209: South Africa Market Share Analysis (%) by Distribution Channel, 2021 & 2032 Figure 210: North Africa Market Value Proportion Analysis, 2021 Figure 211: Global Vs North Africa Growth Comparison, 2021 to 2032 Figure 212: North Africa Market Share Analysis (%) by Product, 2021 & 2032 Figure 213: North Africa Market Share Analysis (%) by Technology, 2021 & 2032 Figure 214: North Africa Market Share Analysis (%) by Distribution Channel, 2021 & 2032
Recommendations
Explore Healthcare Insights
View Reports